There is a growing clinical and scientific interest in catheter-directed therapy (CDT) of acute
pulmonary embolism (PE). Currently, CDT should be considered for patients with high-risk …

Background: Therapeutic options for intermediate-or high-risk pulmonary embolism (PE)
include anticoagulation, systemic thrombolysis and catheter-directed thrombolysis (CDT); …

To compare the efficacy and safety of systemic and catheter directed thrombolysis for
patients with pulmonary embolism. Pubmed and Cochrane Central Register of Controlled …

Background There are increased options to deliver thrombolytic treatment for acute, high-
risk pulmonary embolism (PE). The goals of this study were to examine practice patterns of …

Background Dissecting trends and contributing risk factors for intracranial hemorrhage (ICH)
in patients treated for acute pulmonary embolism (PE) may allow for a better patient …

Catheter-directed thrombolysis (CDT) and systemic thrombolysis (ST) are used to treat
intermediate/high-risk pulmonary embolism (PE) in the absence of comparative safety and …

Pulmonary embolism represents the third most common cause of cardiovascular death in
the United States. Reperfusion therapeutic strategies such as systemic thrombolysis …

Purpose To evaluate changes in the use of catheter-directed therapy (CDT) for pulmonary
embolism (PE) treatment with attention to primary operator specialty in the Medicare …

Background Catheter-directed thrombolysis (CDL) is increasingly being used for the
treatment of submassive and massive pulmonary embolism. Although this therapy has been …

Purpose The aim of this article is to define the place of new endovascular methods for the
management of pulmonary embolisms (PE), on the basis of a multidisciplinary consensus …